<DOC>
	<DOCNO>NCT00593684</DOCNO>
	<brief_summary>The purpose study test safety silver alginate ( Algidex™ ) dress VLBW infant preparation large efficacy trial .</brief_summary>
	<brief_title>The Safety Evaluation Silver Alginate ( Algidex™ ) Dressing Very Low Birth Weight ( VLBW ) Infants</brief_title>
	<detailed_description>We conduct pilot randomize control trial VLBW infant evaluate safety silver alginate ( Algidex™ ) dress compare standard catheter care . Following parental consent , infant randomize receive silver alginate standard care dress . Infants birth weight le 1,500 gram admit Baylor University Medical Center ( BUMC ) NICU follow line eligible inclusion study 72 hour birth : umbilical arterial line ( UAL ) , umbilical venous line ( UVL ) , peripheral arterial line ( PAL ) , peripheral long line ( PLL ) , central venous line ( CVL ) . Safety assess measure silver level monitor cutaneous reaction . Dressings change every seven day . Silver level draw study day 1 , 7 , 28 . Blood culture result use compare infection rate two group . Patient demographic clinical condition record . Results analyze base intention treat .</detailed_description>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Alginic acid</mesh_term>
	<criteria>Infants birth weight le 1,500 gram admit Baylor University Medical Center ( BUMC ) NICU follow line eligible inclusion study 72 hour birth : umbilical arterial line ( UAL ) , umbilical venous line ( UVL ) , peripheral arterial line ( PAL ) , peripheral long line ( PLL ) , central venous line ( CVL ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>72 Hours</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>neonate</keyword>
	<keyword>central line</keyword>
	<keyword>low birth weight</keyword>
	<keyword>silver alginate</keyword>
</DOC>